Cardiac magnetic resonance imaging in patients with coronary disease

Current Treatment Options in Cardiovascular Medicine

Volumn 10, Issue 1, 2008, Pages 83-92

  Wu, Henry D ^b   Kwong, Raymond Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ATROPINE; DOBUTAMINE; GADOLINIUM; VASODILATOR AGENT;

CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE ENHANCEMENT; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

EID: 39049159817     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-008-0009-x     Document Type: Review

References (41)

1. Barkhausen J, Ruehm SG, Goyen M, et al.: MR Evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology 2001, 219:264-269.
2. Nagel E, Lehmkuhl HB, Bocksch W, et al.: Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999, 99:763-770.
3. Hundley WG, Morgan TM, Neagle CM, et al.: Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002, 106:2328-2333.
4. Jahnke C, Nagel E, Gebker R, et al.: Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007, 115:1769-1776.
5. Rerkpattanapipat P, Morgan TM, Neagle CM, et al.: Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol 2002, 90:416-419.
6. Wahl A, Paetsch I, Roethemeyer S, et al.: High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. Radiology 2004, 233:210-216.
7. Paetsch I, Jahnke C, Wahl A, et al.: Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004, 110:835-842.
8. Cheng ASH, Pegg TJ, Karamitsos TD, et al.: Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol 2007, 49:2440-2449.
9. Schwitter J, Nanz D, Kneifel S, et al.: Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001, 103:2230-2235.
10. Nagel E, Klein C, Paetsch I, et al.: Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003, 108:432-437.
11. Giang TH, Nanz D, Coulden R, et al.: Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 2004, 25:1657-1665.
12. Mahrholdt H, Wagner A, Parker M, et al.: Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J Am Coll Cardiol 2003, 42:505-512.
13. Wagner A, Mahrholdt H, Holly TA, et al.: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003, 361:374-379.
14. Ibrahim T, Bulow HP, Hackl T, et al.: Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 2007, 49:208-216.
15. Ricciardi MJ, Wu E, Davidson CJ, et al.: Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001, 103:2780-2783.
16. Kwong RY, Chan AK, Brown KA, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2733-2743.
17. Kim RJ, Fieno DS, Parrish TB, et al.: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
18. Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
19. Klein C, Nekolla SG, Bengel FM, et al.: Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002, 105:162-167.
20. Knuesel PR, Nanz D, Wyss C, et al.: Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 2003, 108:1095-1100.
21. Choi KM, Kim RJ, Gubernikoff G, et al.: Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001, 104:1101-1107.
22. Baer FM, Theissen P, Schneider CA, et al.: Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998, 31:1040-1048.
23. Dendale PAC, Franken PR, Waldman G-J, et al.: Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am Heart J 1995, 130:134-140.
24. Sandstede JJW, Bertsch G, Beer M, et al.: Detection of myocardial viability by low-dose dobutamine cine MR imaging. Magn Reson Imaging 1999, 17:1437-1443.
25. Baer FM, Voth E, Schneider CA, et al.: Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease: a functional and morphological approach to the detection of residual myocardial viability. Circulation 1995, 91:1006-1015.
26. Gunning MG, Anagnostopoulos C, Knight CJ, et al.: Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998, 98:1869-1874.
27. Hundley WG, Hamilton CA, Thomas MS, et al.: Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999, 100:1697-1702.
28. Motoyasu M, Sakuma H, Ichikawa Y, et al.: Prediction of regional functional recovery after acute myocardial infarction with low dose dobutamine stress cine MR imaging and contrast enhanced MR imaging. J Cardiovasc Magn Reson 2003, 5:563-574.
29. Wellnhofer E, Olariu A, Klein C, et al.: Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 2004, 109:2172-2174.
30. Kaandorp TAM, Bax JJ, Schuijf JD, et al.: Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy. Am J Cardiol 2004, 93:1461-1464.
31. Sakuma H, Ichikawa Y, Chino S, et al.: Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 2006, 48:1946-1950.
32. Kim WY, Danias PG, Stuber M, et al.: Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001, 345:1863-1869.
33. Kefer J, Coche E, Legros G, et al.: Head-to-head comparison of three-dimensional navigator-gated magnetic resonance imaging and 16-slice computed tomography to detect coronary artery stenosis in patients. J Am Coll Cardiol 2005, 46:92-100.
34. Klem I, Heitner JF, Shah DJ, et al.: Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006, 47:1630-1638.
35. Kwong RY, Schussheim AE, Rekhraj S, et al.: Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003, 107:531-537.
36. Plein S, Greenwood JP, Ridgway JP, et al.: Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004, 44:2173-2181.
37. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al.: Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004, 109:2411-2416.
38. Aletras AH, Tilak GS, Natanzon A, et al.: Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006, 113:1865-1870.
39. Yan AT, Shayne AJ, Brown KA, et al.: Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114:32-39.
40. Schmidt A, Azevedo CF, Cheng A, et al.: Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007, 115:2006-2014.
41. Arai AE, Hsu L-Y: Myocardial perfusion using first-pass gadolinium-enhanced cardiac magnetic resonance. In Cardiovascular Magnetic Resonance. Edited by Kwong RY. Totowa, NJ: Humana Press; 2007:311.